Universiteit Leiden

nl en

Biopharmaceutics

At the division of Biopharmaceutics, we investigate the mechanisms underlying the development of atherosclerosis, which can cause acute cardiovascular syndromes such as myocardial infarction or stroke.

We mainly focus on modulation of excessive immune responses that occur during the development of atherosclerosis, on the role of the macrophage in the disease process and on plaque stability. 

Read more about our research themes in the research section >